Ulka Sachdev
Vascular Surgery · Tampa, FLNPI 1669585808
Payments from drug & device makers
Across 21 payments — averaging $190.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Penumbra, Inc.$2K
- W. L. Gore & Associates, Inc.$464
- Cook Medical LLC$400
- Medtronic$273
- Bard Peripheral Vascular, Inc.$200
- Inari Medical, Inc.$198
- plus $89 from 1 others
What the payments were for
- Travel & lodging$1,69743%
- Food & beverage$2,29557%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Penumbra, Inc. | 6 | $2,368 |
| W. L. Gore & Associates, Inc. | 3 | $464 |
| Cook Medical LLC | 4 | $400 |
| Medtronic | 2 | $273 |
| Bard Peripheral Vascular, Inc. | 3 | $200 |
| Inari Medical, Inc. | 1 | $198 |
| Boston Scientific | 2 | $89 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Indigo System$2,200
- ClosureFast$211
- GORE VIABAHN VBX Balloon Expandable Endo$203
- FLOWTRIEVER CATHETER, S$198
- CT THROMBECTOMY SYSTEM KIT$198
- Penumbra System$168
- GORE EXCLUDER AAA Endoprosthesis$160
- Zenith Spiral-Z$143
- Zilver PTX$117
- Venclose Maven Catheter$106
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$101
How this compares
$3,992 in reported general payments places this provider in the 35th percentile of 385 vascular surgery providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 30 | $23,439 |
| XareltoRivaroxaban | 22 | $20,738 |
| ClopidogrelClopidogrel Bisulfate | 50 | $520 |
| Cilostazol | 12 | $324 |
| Atorvastatin Calcium | 17 | $163 |
| Prednisone | 11 | $37 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Tampa
- Murray ShamesTampa$354K
- Martin BackTampa$303K
- K Dean ArnaoutakisTampa$271K
- Charles BaileyTampa$180K
- Charles BriggsTampa$102K
- Halim YammineTampa$92K
- Diego AyoTampa$76K
- Karl IlligTampa$76K
- Samuel TapperStuart$1.3M
- Erin MooreJacksonville$488K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.